1 Psycho-Oncology Cooperative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, NSW, Australia. madeleine.king@sydney.edu.au.
2 Central Clinical School, Sydney Medical School, Faculty of Medicine, University of Sydney, Sydney, NSW, Australia. madeleine.king@sydney.edu.au.
3 Psycho-Oncology Cooperative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, NSW, Australia.
4 Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
5 Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, South Yorkshire, UK.
6 Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
7 Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
8 Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
9 Chris O'Brien Lifehouse, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
10 School of Public Health, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia.
11 Department of Psychiatry and Psychotherapy, Innsbruck Medical University, Innsbruck, Austria.
12 School of Public Health, Curtin University, Perth, WA, Australia.
13 Centre for Health Economics Research and Evaluation (CHERE), University of Technology Sydney (UTS), Sydney, NSW, Australia.
14 Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA.
15 Leeds Institute of Cancer and Pathology, University of Leeds, St James's University Hospital, Leeds, UK.